Publications by authors named "Laura Kummer"

Claim this Profile
T
TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccination.
Laura Yl Kummer, Lisan H Kuijper, Laura Fernández Blanco, Amélie Bos, Christine Kreher

RMD Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy.
Nicoline F van Buchem-Post, Wouter Ouwerkerk, Eileen W Stalman, Koos P J van Dam, Luuk Wieske, Laura Y L Kummer

J Dermatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anserine reduces mortality in experimental sepsis by preventing methylglyoxal-induced capillary leakage.
Thomas Schmoch, Nadia Gallenstein, Verena Peters, Maria Bartosova, Florian Uhle, Laura Kummer

EBioMedicine· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of SARS-CoV-2 antibody repertoire after successive mRNA vaccinations under immunosuppressive treatment.
Jim B D Keijser, Eileen W Stalman, Luuk Wieske, Maurice Steenhuis, Koos P J van Dam, Laura Y L Kummer

EBioMedicine· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported daily functioning after SARS-CoV-2 vaccinations in autoimmune neuromuscular diseases.
Koos P J van Dam, Luuk Wieske, Eileen W Stalman, Laura Y L Kummer, Anneke J van der Kooi

Eur J Neurol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to letter to the editor regarding "low intraoperative end-tidal carbon dioxide levels are associated with improved recurrence-free survival after elective colorectal cancer surgery".
Sarah Dehne, Lina Kirschner, Moritz J Strowitzki, Samuel Kilian, Laura C Kummer

J Clin Anesth· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMID.
Laura Y L Kummer, Laura Fernández Blanco, Christine Kreher, Amélie Bos, Lisan H Kuijper

RMD Open· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low intraoperative end-tidal carbon dioxide levels are associated with improved recurrence-free survival after elective colorectal cancer surgery.
Sarah Dehne, Lina Kirschner, Moritz J Strowitzki, Samuel Kilian, Laura Christine Kummer

J Clin Anesth· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy.
Eileen W Stalman, Luuk Wieske, Jim B D Keijser, Koos P J van Dam, Laura Y L Kummer

J Allergy Clin Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination.
Niels J M Verstegen, Ruth R Hagen, Christine Kreher, Lisan H Kuijper, Jet van den Dijssel, Laura Y L Kummer

J Neurol Neurosurg Psychiatry· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination.
Anika M Valk, Jim B D Keijser, Koos P J van Dam, Eileen W Stalman, Luuk Wieske, Laura Y L Kummer

Allergy· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8 T cell responses.
Jet van den Dijssel, Mariël C Duurland, Veronique Al Konijn, Laura Yl Kummer, Ruth R Hagen

J Autoimmun· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal increase of humoral responses after four SARS-CoV-2 vaccinations and infection in MS patients on fingolimod.
Zoé LE van Kempen, Koos Pj van Dam, Jim Bd Keijser, Eileen W Stalman, Laura Yl Kummer

Mult Scler· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection.
Sofie Keijzer, Nienke Oskam, Pleuni Ooijevaar-de Heer, Maurice Steenhuis, Jim B D Keijser, Laura Y L Kummer

Front Immunol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases.
Luuk Wieske, Eileen W Stalman, P J Koos van Dam, Laura Y Kummer, Maurice Steenhuis

Ann Rheum Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.
Koos P J van Dam, Adriaan G Volkers, Luuk Wieske, Eileen W Stalman, Laura Y L Kummer

BMC Infect Dis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis.
Zoé L E van Kempen, Eileen W Stalman, Maurice Steenhuis, Laura Y L Kummer, Koos P J van Dam

J Neurol Neurosurg Psychiatry· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations.
Koos P J van Dam, Luuk Wieske, Eileen W Stalman, Laura Y L Kummer, Jesse Roosen

J Autoimmun· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple Sclerosis.
Zoé L E van Kempen, Laura Hogenboom, Alyssa A Toorop, Maurice Steenhuis, Eileen W Stalman, Laura Y L Kummer

Ann Neurol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases.
Eileen W Stalman, Luuk Wieske, Koos P J van Dam, Laura Y Kummer, Zoé L E van Kempen

Ann Rheum Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination.
Koos P J van Dam, Laura Hogenboom, Eileen W Stalman, Laura Y L Kummer, Maurice Steenhuis

Front Neurol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod.
Virginia Palomares Cabeza, Laura Y L Kummer, Luuk Wieske, Ruth R Hagen, Mariel Duurland

Neurol Neuroimmunol Neuroinflamm· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273.
Niels J M Verstegen, Ruth R Hagen, Jet van den Dijssel, Lisan H Kuijper, Christine Kreher, Laura Y L Kummer

Elife· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies.
Laura Boekel, Eileen W Stalman, Luuk Wieske, Femke Hooijberg, Koos P J van Dam, Laura Y L Kummer

Lancet Rheumatol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study.
Laura Boekel, Femke Hooijberg, Erik H Vogelzang, Yaëlle R Besten, Maureen Leeuw, Laura Y Kummer

RMD Open· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis